Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer
Decline of serum CYFRA21-1 during chemoradiotherapy of NSCLC: a probable predictive factor for tumor response
CYFRA21-1 as a Serum Tumor Marker for Follow-Up Patients with Squamous Cell Lung Carcinoma and Oropharynx Squamous Cell Carcinoma
CEA, CYFRA21-1 and SCC in non-small cell lung cancer
A photoelectrochemical biosensor based on an MXene-based Ti3C2Tx/g-C3N4/CdSe heterojunction and AgInS2 amplification for the detection of Cyfra21–1